Inventiva’s lead product candidate, lanifibranor, is currently in a pivotal Phase III clinical trial, NATiV3, for the treatment of adult patients with MASH, a common and progressive chronic liver ...

2024 and the Annual Report on Form 20-F for the year ended December 31, 2023 filed with the Securities and Exchange Commission (the “SEC”) on April 3, 2024 and the Half-Year Report for the six ...

January 24, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused ...

In a report released on January 27, Sebastien Sztabowicz from Kepler Capital maintained a Sell rating on Telefonaktiebolaget LM Ericsson Class B (0O87 – Research Report), with a price target of ...

Telefonaktiebolaget Lm Ericsson (publ) (NASDAQ: ERIC) Q4 2024 Earnings Call Jan 24, 2025, 3:00 a.m. ET ...

Waves of intense cold will send temperatures plunging as much as 20F (11C) below normal across the central and eastern US this month, triggering ice storms that could down power lines and snarl ...

For more information, please refer to the Notes To Combined And Consolidated Financial Statements in the Company's annual report on Form 20-F for the fiscal year ended September 30, 2024.

Donald Trump will be sworn in today as the 47th president of the United States, a couple of months after one of the most polarized presidential elections in US history. His inauguration coincides ...

Whether they played superheroes, killers, gladiators or chefs, these young Hollywood stars — i.e. under the age of 35 — leapt off the screen in 2024, but they’re on tap to do even bigger ...

If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...

Few pop culture properties are as polarising as the Crazy Frog. Some found him so endearing. A little animated creature mimicking the sound of a motorcycle, hooning around to Harold Faltermeyer's ...